Formation Bio – Talk Bio

Actionable Insights Powered by AI

Formation Bio Eyes Abivax-Like Success with Chinese Drug Licensing Deal Targeting Same Mechanism

19 hours ago talkbio0Tagged Abivax, Antineoplastic Agents, China, Formation Bio, PD-1/VEGF

Formation Bio; Abivax; licensing deal; China; cancer drug; PD-1/VEGF; biotech